Carlson Tsui

9PUBLICATIONS
109CO-AUTHORS
Haematological tumoursInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 28, 2025
Transcriptional regulator SATB1 limits CD8+ T cell population expansion and effector differentiation in chronic infection and cancer.

Leonie Heyden, Lisa Rausch, Michael H Shannon

|Sep 15, 2025
Lymph nodes fuel KLF2-dependent effector CD8+ T cell differentiation during chronic infection and checkpoint blockade.

Carlson Tsui, Leonie Heyden, Lifen Wen

|Jul 29, 2025
Lymph-node-derived stem-like but not tumor-tissue-resident CD8+ T cells fuel anticancer immunity.

Sharanya K M Wijesinghe, Lisa Rausch, Sarah S Gabriel

|Jan 31, 2025
Stem-like memory and precursors of exhausted T cells share a common progenitor defined by ID3 expression.

Catarina Gago da Graça, Amania A Sheikh, Dane M Newman

|Aug 28, 2024
NaCl enhances CD8+ T cell effector functions in cancer immunotherapy.

Caterina Scirgolea, Rosa Sottile, Marco De Luca

|Mar 01, 2024
TGF-β specifies TFH versus TH17 cell fates in murine CD4+ T cells through c-Maf.

Yinshui Chang, Luisa Bach, Marko Hasiuk

Pageof 2

Frequent Collaborators

8 joint publications

Axel Kallies

5 joint publications

Daniel T Utzschneider

4 joint publications

David Chisanga

4 joint publications

Marc D Beyer